GIGABEAM CORPORATIONTermination of Securities Purchase Agreement • January 31st, 2008 • Gigabeam Corp • Radio & tv broadcasting & communications equipment
Contract Type FiledJanuary 31st, 2008 Company IndustryThis letter confirms our understanding and acknowledgement that the Securities Purchase Agreement, dated August 16, 2007, and the transactions contemplated thereunder, are hereby terminated pursuant to Section 5.1 therein as a result of the closing of said transaction failing to close on or before August 31, 2007 as well as the mutual understanding and agreement of the parties thereto. As such, the obligations of GigaBeam Corporation (the “Company”) under the 14% Secured Debenture issued pursuant to the Securities Purchase Agreement, dated May 22, 2007 (the “Purchase Agreement”), was not paid off pursuant to such agreement and remains outstanding pursuant to the terms thereunder and in full force and effect. Furthermore, the Company agrees that certain cash advances made by Midsummer Investment, Ltd. (“Midsummer”) on or about August 16, 2007 in the amount of $500,000 and on or about November 30, 2007 in the amount of $400,000 shall be evidenced by the issuance by the Company of 14% Pro
TERMINATION OF SECURITIES PURCHASE AGREEMENTTermination of Securities Purchase Agreement • August 1st, 2022 • Breeze Holdings Acquisition Corp. • Blank checks • New York
Contract Type FiledAugust 1st, 2022 Company Industry JurisdictionThis tERMINATION OF Securities Purchase Agreement (this “Termination”) is dated as of July 28, 2022, among Breeze Holdings Acquisition Corp., a Delaware corporation (“SPAC”), D-Orbit S.A., a joint stock company (société anonyme) governed by the laws of the Grand Duchy of Luxembourg with its registered office at 9, rue de Bitbourg, L1273 Luxembourg, Grand Duchy of Luxembourg and registered with the Luxembourg trade and companies register (Registre de Commerce et des Sociétés, Luxembourg) under number B 261356 (“PubCo”), D-Orbit S.p.A., an Italian Società per azioni (the “Target”) and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”). Each of SPAC, PubCo, the Target and each Purchaser shall each individually be referred to herein as a “Party” and, collectively as the “Parties”. Reference is made to that certain Securities Purchase Agreement, dated as of January 25, 2022, by and among the
April 11, 2013Termination of Securities Purchase Agreement • April 12th, 2013 • Infinity Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
Contract Type FiledApril 12th, 2013 Company Industry JurisdictionThis letter agreement (this “Agreement”) confirms the agreement among Infinity Pharmaceuticals, Inc., a Delaware corporation (the “Company”), Purdue Pharma L.P. (“Purdue”), Beacon Company (“Beacon”) and Rosebay Medical Company L.P. (“Rosebay” and, together with Purdue and Beacon, the “BRP Entities”) regarding the termination of the Securities Purchase Agreement dated as of July 17, 2012, as amended by that certain letter agreement dated as of April 9, 2013, among the Company and the BRP Entities (together, the “Purchase Agreement”), as set forth in greater detail below. Defined terms used herein but not otherwise defined herein shall have the meaning given to them in the Purchase Agreement.